NMTC - NeuroOne Medical Technologies Corp Stock Price, Fair Value and News

$0.68+0.02 (+3.03%)

Market Closed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

NMTC Price Action

Last 7 days

-2.9%

Last 30 days

-10.5%

Last 90 days

-6.8%

Trailing 12 Months

4.6%

NMTC RSI Chart

NMTC Valuation

Market Cap

34.0M

Price/Earnings (Trailing)

-6.37

Price/Sales (Trailing)

11.33

EV/EBITDA

-5.12

Price/Free Cashflow

-10

NMTC Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

NMTC Fundamentals

NMTC Revenue

Revenue (TTM)

3.0M

Rev. Growth (Yr)

105.39%

Rev. Growth (Qtr)

-100%

NMTC Earnings

Earnings (TTM)

-5.3M

Earnings Growth (Yr)

45.77%

Earnings Growth (Qtr)

33.9%

NMTC Profitability

Operating Margin

4.16%

EBT Margin

-177.89%

Return on Equity

-65.26%

Return on Assets

-49.33%

Free Cashflow Yield

-10%

NMTC Investor Care

Shares Dilution (1Y)

62.27%

Diluted EPS (TTM)

-0.15

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2025	3.0M	3.0M	0	0
2024	0	0	0	3.0M
2023	813.2K	1.1M	1.5M	0
2022	28.8K	100.0K	171.2K	492.2K
2021	1.0M	567.2K	114.0K	48.9K
2020	0	0	1.9M	1.5M
2014	1.6M	0	0	0
2013	331.1K	650.2K	969.3K	1.3M
2012	0	0	0	12.0K
2011	0	0	0	5.4K
2010	0	0	0	0

Get all data in R, Python etc through our Historical Stock Data APIs

About NeuroOne Medical Technologies Corp

NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other related neurological disorders. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator. The company was incorporated in 2009 and is based in Eden Prairie, Minnesota.

CEO	Mr. David A. Rosa M.D.
WEBSITE	n1mtc.com
SECTOR	Healthcare
INDUSTRY	Medical Devices
EMPLOYEES	15

NeuroOne Medical Technologies Corp Frequently Asked Questions

What is the ticker symbol for NeuroOne Medical Technologies Corp? What does NMTC stand for in stocks?

NMTC is the stock ticker symbol of NeuroOne Medical Technologies Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of NeuroOne Medical Technologies Corp (NMTC)?

As of Wed Dec 03 2025, market cap of NeuroOne Medical Technologies Corp is 34 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of NMTC stock?

You can check NMTC's fair value in chart for subscribers.

Is NeuroOne Medical Technologies Corp a good stock to buy?

The fair value guage provides a quick view whether NMTC is over valued or under valued. Whether NeuroOne Medical Technologies Corp is cheap or expensive depends on the assumptions which impact NeuroOne Medical Technologies Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for NMTC.

What is NeuroOne Medical Technologies Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Dec 03 2025, NMTC's PE ratio (Price to Earnings) is -6.37 and Price to Sales (PS) ratio is 11.33. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. NMTC PE ratio will change depending on the future growth rate expectations of investors.